The following is a summary of “Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Musician's Experience After Breast Cancer Treatment: Defining Musical Toxicity and its Frequency Fig 1. Summary of key NACT for advanced EOC recommendations. C, conditional; ECOG, Eastern Cooperative ...

Among patients with platinum-sensitive peritoneal recurrent epithelial ovarian cancer undergoing secondary cytoreductive surgery (SCS), the addition of hyperthermic intraperitoneal chemotherapy (HIPEC ...

To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal ...

MUSTAFA RAOOF ONCOLOGY Assistant Professor, Division of Surgical Oncology, Department of Surgery; Assistant Professor, Department of Cancer Genetics and ...

First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment ...

Adding hyperthermic intraperitoneal chemotherapy (HIPEC) to cytoreductive surgery significantly improved overall survival (OS) in women with platinum-sensitive, recurrent epithelial ovarian ...